Trials / Unknown
UnknownNCT06129669
ICG Indocyanine Green in Reconstructive Surgery
Determining Critical Thresholds of Tissue Perfusion With ICG in Reconstructive Surgery
- Status
- Unknown
- Phase
- —
- Study type
- Observational
- Enrollment
- 160 (estimated)
- Sponsor
- Amsterdam UMC, location VUmc · Academic / Other
- Sex
- All
- Age
- 18 Years – 110 Years
- Healthy volunteers
- Accepted
Summary
The success or failure of a reconstruction is largely related to the vascularization of the operated area. Near infrared fluorescence (also near infrared fluorescence angiography, NIR FA) with ICG administration is an innovative technique to quantify tissue perfusion. Based on the results obtained in other subspecialties, NIR fluorescence appears to be a promising way to quantify tissue perfusion in reconstructive surgery. Fluorescence research has previously been used in the context of microsurgery and breast reconstructions using implants, but structural objective determinations are lacking. Our study is successful if we are able to determine a cut off value for the absolute or relative perfusion parameters.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Indocyanine green | Administration of ICG during surgery and recording of the fluorescence video to perform data analyses |
Timeline
- Start date
- 2023-05-09
- Primary completion
- 2025-05-01
- Completion
- 2025-05-01
- First posted
- 2023-11-13
- Last updated
- 2023-11-13
Locations
1 site across 1 country: Netherlands
Regulatory
- FDA-regulated drug study
Source: ClinicalTrials.gov record NCT06129669. Inclusion in this directory is not an endorsement.